Literature DB >> 26114349

Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension.

Mahir Cengiz1, Serap Yavuzer1, Burçak Kılıçkıran Avcı2, Mehmet Yürüyen1, Hakan Yavuzer1, Süleyman Atilla Dikici3, Ömer Faruk Karataş4,5, Mustafa Özen4,6, Hafize Uzun7, Zeki Öngen2.   

Abstract

OBJECTIVES: The aim of this study is to evaluate the relationship of miR-21, nitric oxide (NOx) and endothelial nitric oxide synthase (eNOS) with subclinical atherosclerosis in carotid arteries by measuring carotid intima media thickness (CIMT) in patients with hypertension and healthy controls. DESIGN AND METHODS: A total of 28 hypertensive and 28 healthy controls were enrolled. MiR-21 expression was analyzed by quantitative reverse transcription-PCR and NOx, and eNOS levels were measured by ELISA assay. CIMT was evaluated by ultrasonography and CIMT ≥ 0.8 mm was accepted as increased CIMT (iCIMT).
RESULTS: C-reactive protein (CRP) level, plasma miR-21 expression level and CIMT were found to be significantly higher in the hypertension group when compared to the control group (p = 0.009, p = 0.002 and p < 0.001, respectively). NOx and eNOS levels were significantly lower in the hypertension group compared to the control group (p < 0.001, both). MiR-21 level was positively correlated with the clinical systolic blood pressure, clinical diastolic blood pressure, CRP and CIMT. MiR-21 was also negatively correlated with NOx and eNOS. Eighteen patients with hypertension had iCIMT. MiR-21 and CRP levels were significantly higher (p < 0.001 and p = 0.001), whereas NOx and eNOS levels were significantly lower in patients with iCIMT (p < 0.001, both).
CONCLUSION: The decreased levels of NOx and eNOS found in this study indicate the co-existence of endothelial dysfunction and hypertension once more. In the absence of microalbuminuria, the increased miR-21 expression in patients with iCIMT made us conclude that this miRNA might be involved in the early stages of atherosclerotic process in hypertensive patients.

Entities:  

Keywords:  Carotid intima media thickness; endothelial nitric oxide synthase; hypertension; microRNA-21; nitric oxide

Mesh:

Substances:

Year:  2015        PMID: 26114349     DOI: 10.3109/10641963.2015.1036064

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  31 in total

1.  Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis.

Authors:  Jing-Yun Zhang; Ying-Lan Gong; Chun-Jun Li; Qi Qi; Qiu-Mei Zhang; De-Min Yu
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 2.  Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Authors:  Roopesh S Gangwar; Sanjay Rajagopalan; Rama Natarajan; Jeffrey A Deiuliis
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

Review 3.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

4.  Molecular mechanisms in vascular injury induced by hypertension: Expression and role of microRNA-34a.

Authors:  Siguan Liu; Fanfan Yi; Wenwei Cheng; Xin Qu; Chunting Wang
Journal:  Exp Ther Med       Date:  2017-09-27       Impact factor: 2.447

Review 5.  Relevance of microRNA 21 in Different Types of Hypertension.

Authors:  Durairaj Sekar; B R Shilpa; Anupam J Das
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

Review 6.  HDL and microRNA therapeutics in cardiovascular disease.

Authors:  Danielle L Michell; Kasey C Vickers
Journal:  Pharmacol Ther       Date:  2016-09-03       Impact factor: 12.310

7.  Identification of miR-17, miR-21, miR-27a, miR-106b and miR-222 as endoplasmic reticulum stress-related potential biomarkers in circulation of patients with atherosclerosis.

Authors:  Pelin Telkoparan-Akillilar; Dilek Cevik
Journal:  Mol Biol Rep       Date:  2021-04-15       Impact factor: 2.316

Review 8.  Differential and targeted vesiculation: pathologic cellular responses to elevated arterial pressure.

Authors:  Paul A Brown
Journal:  Mol Cell Biochem       Date:  2022-01-06       Impact factor: 3.396

Review 9.  Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension.

Authors:  Chenggui Miao; Jun Chang; Guoxue Zhang
Journal:  Mol Biol Rep       Date:  2018-10-08       Impact factor: 2.316

Review 10.  Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.

Authors:  Perry V Halushka; Andrew J Goodwin; Marc K Halushka
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.